Stanton Myrum - ProUroCare Medical CEO and Director
| PUMDDelisted Stock | USD 0.0001 0.00 0.00% |
CEO
Mr. Stanton Myrum was appointed as Interim Chief Executive Officer, Director of Prourocare Medical Inc., effective April 19, 2013 since 2013.
| Age | 73 |
| Tenure | 11 years |
| Phone | 952-476-9093 |
| Web | http://www.prourocare.com |
ProUroCare Medical Management Efficiency
The company has return on total asset (ROA) of (0.6095) % which means that it has lost $0.6095 on every $100 spent on assets. This is way below average. ProUroCare Medical's management efficiency ratios could be used to measure how well ProUroCare Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | CEO Age | ||
| Maarten Edixhiven | Aegon NV ADR | 49 | |
| Jeffrey Quartermaine | Perseus Mining Limited | N/A | |
| Marco Keim | Aegon NV ADR | 59 | |
| Mark Mullin | Aegon NV ADR | 56 | |
| Bas NieuWeme | Aegon NV ADR | 49 | |
| Mike HollidayWilliams | Aegon NV ADR | 51 | |
| Adrian Grace | Aegon NV ADR | 56 | |
| Sarah Russell | Aegon NV ADR | 57 | |
| Lard Friese | Aegon NV ADR | 62 | |
| Gabor Kepecs | Aegon NV ADR | 62 | |
| Vince Coppola | IPG Photonics | N/A | |
| Allegra HovellPatrizi | Aegon NV ADR | 47 | |
| Lisa Su | Advanced Micro Devices | 54 | |
| Will Fuller | Aegon NV ADR | N/A | |
Management Performance
| Return On Asset | -0.61 |
ProUroCare Medical Leadership Team
Elected by the shareholders, the ProUroCare Medical's board of directors comprises two types of representatives: ProUroCare Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProUroCare. The board's role is to monitor ProUroCare Medical's management team and ensure that shareholders' interests are well served. ProUroCare Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProUroCare Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stanton Myrum, CEO and Director | ||
| Scott Smith, Independent Director | ||
| RAC JD, Consultant | ||
| Alan Shuler, CFO and Secretary | ||
| James Davis, Chairman of the Board | ||
| David Kaysen, Director | ||
| David MD, Consultant |
ProUroCare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ProUroCare Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.61 | |||
| Current Valuation | 1.73 M | |||
| Shares Outstanding | 18.6 M | |||
| Price To Earning | (0.05) X | |||
| EBITDA | (462.3 K) | |||
| Net Income | (2.96 M) | |||
| Cash And Equivalents | 970 | |||
| Current Ratio | 0.06 X | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (1.12 M) |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ProUroCare Medical using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in ProUroCare Stock
If you are still planning to invest in ProUroCare Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ProUroCare Medical's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |